CIMIT (Center for Integration of Medicine & Innovative Technology)

What CIMIT (Center for Integration of Medicine & Innovative Technology) does

CIMIT (Center for Integration of Medicine & Innovative Technology) is a nonprofit health impact accelerator founded in 1998 and headquartered at 125 Nashua St., Boston, MA. It operates as the coordinating center for NIH's Point-of-Care Technologies Research Network (POCTRN) and served as the central operational partner for the RADx Tech program launched in 2020 in response to COVID-19, a role credited with producing 46 Emergency Use Authorizations and approximately 8 billion diagnostic tests delivered globally. The organization runs a structured innovation funnel — competitive challenges, expert review gates, grant funding, and commercialization mentorship — that has supported more than 1,000 health innovations with a stated 50% commercialization success rate.

CIMIT's core products are a suite of proprietary, trademarked management and assessment tools: GAITS (Guidance and Impact Tracking System), a web-based project and portfolio management platform tracking innovations across 10 maturity stages and four domains (clinical, market/business, regulatory, technology); CoLab, a secure proposal management platform; the Risk Assessment Score (RAS), a predictive risk evaluation tool; and CRAASH, a hands-on commercialization accelerator course. These tools are deployed in service of NIH-funded programs including POCTRN, RADx Tech, ITAP (Independent Test Assessment Program, run jointly with the FDA), CINTA (Center for Innovative NeuroTech Advancement), and maternal/fetal health and HIV viral load challenges.

CIMIT's revenue model is effectively a federal grant administration and program-operating business: it is funded through NIH/NIBIB grants and partner-sponsored programs from foundations and other nonprofits, with no disclosed commercial pricing. Its customer base consists of government health agencies, academic medical centers, and the healthcare innovators and startups it supports (e.g., Motif Neurotech, Neurava, Cepheid, 1Drop Diagnostics, Photonicare). The organization has a small core team (approximately 1-15 staff) and functions as a hub connecting multidisciplinary experts in science, medicine, engineering, and business with the health technology projects it accelerates.

Name

CIMIT (Center for Integration of Medicine & Innovative Technology)

Legal name

CIMIT (Center for Integration of Medicine & Innovative Technology)

Website

https://cimit.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

CIMIT is a Boston-based nonprofit health impact accelerator founded in 1998 that runs NIH-funded innovation programs, most notably the POCTRN coordinating center and the RADx Tech COVID-19 diagnostics initiative, using proprietary tools (GAITS, CoLab, RAS, CRAASH) to identify, fund, and commercialize health technologies for government, academic, and startup partners.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. NIH Grant Funding: Primary funding comes from NIH through various programs including POCTRN coordination, RADx Tech initiatives, Blueprint MedTech, and other health innovation programs. CIMIT receives federal funds to design, implement, and oversee innovation programs.
2. Partner-Sponsored Programs: Funding from government agencies, foundations, and nonprofit partners to advance specific health innovation projects and challenges.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

CIMIT is a nonprofit health impact accelerator that identifies, funds, mentors, and shepherds promising health technology projects from concept to commercialization. It delivers this through competitive funding programs (e.g., RADx Tech, POCTRN, ITAP, CINTA, Maternal Health Challenges), hands-on facilitation by multidisciplinary experts, and proprietary tools (GAITS, CoLab, RAS, CRAASH) that provide project tracking, proposal management, risk assessment, and commercialization training.

Product overview

CIMIT is a nonprofit health impact accelerator that offers a suite of proprietary tools designed to identify promising health innovation projects and manage their development. The core product portfolio includes: CIMIT GAITS (Guidance and Impact Tracking System) for project and portfolio management across 10 maturity stages and four domains; CIMIT CoLab for streamlined proposal management and application review; CIMIT Risk Assessment Score (RAS) for risk evaluation and commercialization success prediction; and CIMIT CRAASH for hands-on commercialization education. These tools collectively support CIMIT's mission to advance groundbreaking health solutions through hands-on facilitation, proven processes, customized tools, and access to a global network of multidisciplinary experts.

Differentiator

Problem solved

Functional benefit

Products and services

• CIMIT GAITS (Guidance and Impact Tracking System) Web-based project and portfolio management platform that helps innovators track progress and de-risk projects across four critical domains (clinical, market/business, regulatory/approvals, and technology) and 10 distinct maturity stages. Used by program partners including NIH and other government agencies.
• CIMIT CoLab Secure, web-based proposal management platform that streamlines the innovator application process and provides insights to partners, featuring collaborative workspaces, customizable forms, longitudinal records, metrics tracking and reporting, and milestone monitoring.
• CIMIT Risk Assessment Score (RAS) Tool used to systematically evaluate risk and predict the probability of a project achieving commercial success, providing objective risk evaluation, comprehensive risk assessment across multiple categories, and targeted risk mitigation strategies.
• CIMIT CRAASH Accelerator Course Intensive, hands-on educational program that fast-tracks commercialization of healthcare innovations, covering discovery interviews, healthcare innovation process, identifying economic buyers, clinical needs, sustainable business models, market adoption, regulatory navigation, intellectual property protection, and investor pitching.
• RADx Tech (Rapid Acceleration of Diagnostics) Program NIH-funded program coordinated by CIMIT to rapidly accelerate development, validation, and commercialization of COVID-19 and other diagnostic technologies through an innovation funnel with deep-dive review, milestone-based funding, and regulatory support via ITAP.
• POCTRN (Point-of-Care Technologies Research Network) Coordination Coordination of a multidisciplinary NIH-funded network of six academic scientific centers developing innovative point-of-care and at-home health technologies for conditions including heart disease, cancer, and HIV/AIDS.
• ITAP (Independent Test Assessment Program) Program that facilitates FDA collaboration with NIBIB to fast-track regulatory review and authorization of diagnostic tests, including multiplex tests and the first hepatitis C point-of-care test.
• CINTA (Center for Innovative NeuroTech Advancement) NIH Blueprint MedTech program that solicits, evaluates, and funds neurotechnology development projects, including Optimizer and Seedling awards, with a focus on inclusivity and equity in neurotech development.
• Maternal and Fetal Health Challenges Series of challenge competitions funded by NICHD, NIBIB, and CIMIT to accelerate development of maternal and fetal health technologies that improve reproductive and fetal health outcomes globally.

Quantifiable outcome

• 50% commercialization success rate for supported projects
• +6 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• NIH Office of AIDS ResearchcoreStrategic or Co-development Partner · 1 January 2024Partnered with NIBIB and CIMIT on RADx Tech HIV viral load testing programs to rapidly advance development and regulatory approval of innovative point-of-care HIV viral load testing and monitoring platforms.
• Cornell PORTENT (Center for Point-of-Care Technologies for Nutrition, Infection, and Cancer)minorStrategic or Co-development Partner · 1 January 2024PORTENT focuses on developing enhanced point-of-care diagnostics aimed at reducing delays and improving access for crucial healthcare across the globe. Backed five new technologies to expand access to care.
• NeuroTech HarborcoreStrategic or Co-development Partner · 1 January 2023NeuroTech Harbor serves as one of two Blueprint MedTech Incubator Hubs (alongside CIMIT's CINTA) to solicit, evaluate, and oversee neurotechnology development projects. Partnership between Johns Hopkins University and Howard University committed to inclusivity and equity in neurotech development.
• NICHD (Eunice Kennedy Shriver National Institute of Child Health and Human Development)coreStrategic or Co-development Partner · 1 January 2022NICHD partnered with NIBIB and CIMIT to launch a series of maternal and fetal health challenges to accelerate development of technologies advancing reproductive and fetal health outcomes globally.
• FDA (Food and Drug Administration)coreStrategic or Co-development Partner · 1 January 2021FDA collaborates with NIBIB through the ITAP program to fast-track regulatory review and availability of diagnostic tests. Partnership facilitated authorization of multiplex tests, hepatitis C tests, and other diagnostics.
• Forsyth InstituteminorStrategic or Co-development Partner · 25 August 2020World leader in oral biology and salivary diagnostics working with NIH RADx as an advisor and resource for saliva-based COVID-19 test development. Forsyth brings century of saliva research experience and unique expertise in developing saliva-based tests.
• VentureWellcoreStrategic or Co-development Partner · 1 January 2020CIMIT works with VentureWell as part of the RADx Tech initiative, which is implemented in conjunction with NIH, VentureWell, and four POCTRN centers.
• University Lab PartnersminorStrategic or Co-development Partner · 1 January 2020Southern California biotech/medtech incubator selected by CIMIT to partner in support of the NIH RADx initiative, helping accelerate commercialization and deployment of COVID-19 testing technologies.
• POCTRN Centers (Six institutions)coreStrategic or Co-development Partner · 1 January 2018Six institutions serve as scientific centers within POCTRN, addressing unmet testing, monitoring, and treatment needs for conditions such as heart disease, cancer, and HIV/AIDS. CIMIT coordinates collaboration among these centers.
• NIH/NIBIB (National Institute of Biomedical Imaging and Bioengineering)coreStrategic or Co-development Partner · 1 January 2007CIMIT has served as the coordinating center for POCTRN since 2018, previously as a scientific center since 2012. The partnership involves designing and implementing health technology innovation programs including RADx Tech, with CIMIT employing its expertise, proven methodology, expert network, and tools for project management and risk assessment throughout the innovation process.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• MATTER: Chicago-based health tech incubator and accelerator supporting early-stage healthcare startups with mentorship, curriculum, and corporate partnerships — directly comparable as a health-innovation accelerator with a non-equity program model.
• MedTech Innovator: Largest medical device accelerator running cohort-based programs with corporate sponsors and FDA engagement; competes for the same pool of health-tech founders and operates a structurally similar accelerator funnel.
• MassChallenge HealthTech: Nonprofit health-tech accelerator affiliated with the Boston innovation ecosystem; closest direct peer given shared nonprofit model, geographic overlap, and focus on connecting startups with healthcare enterprises.
• Fogarty Institute for Innovation: Nonprofit health-tech incubator housed at El Camino Hospital that mentors and funds early-stage medical device innovators; closely comparable mission, structure, and stage focus as CIMIT.

Broad incumbents

• Johnson & Johnson Innovation – JLABS: Corporate-sponsored life-science incubator network offering lab space, mentorship, and capital to early-stage medtech and biotech startups; broader incumbent with deeper capital backing and global footprint than CIMIT.
• Plug and Play Tech Center (Health vertical): Global corporate-backed accelerator running dedicated health/biotech batches with enterprise partners; comparable in operating a cohort-driven model for health innovators, though with a commercial/equity-aligned structure.

Emerging players

• IndieBio: Biotech-focused accelerator providing seed capital, lab space, and mentorship; partially overlaps with CIMIT on health/life-science startup support but operates a for-profit, equity-taking model.

Regional players

• UCSF Rosenman Institute: University-anchored health-tech accelerator based at UCSF focused on biomedical startups in the Bay Area; comparable as an academic-medical-center-aligned accelerator serving a regional founder pool.
• StartX: Stanford-affiliated nonprofit accelerator supporting founders across sectors including healthcare and biotech; comparable nonprofit accelerator model with a regional (Silicon Valley) mandate.
• BioGenerator: St. Louis-based nonprofit life-science startup support organization that funds and mentors biotech and medtech founders; comparable nonprofit accelerator role with similar funding-plus-mentorship offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/center-for-integration-of-medicine-and-innovative-technology
• Instagraminstagram.com/cimitboston
• Xx.com/cimit
• Facebookfacebook.com/137211029693836

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIMIT (Center for Integration of Medicine & Innovative Technology)